NCT02563197View on ClinicalTrials.gov

Inhalation Flow Rate-study

PHASE1CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

November 23, 2015

Primary Completion Date

February 17, 2016

Study Completion Date

April 29, 2016

Conditions
Bronchiectasis
Interventions
DEVICE

T-326 Inhaler

No drug dosing,three test inhalations through the inhaler device filled with an empty capsule.

Trial Locations (10)

22927

Großhansdorf

30625

Hanover

60389

Frankfurt am Main

60596

Frankfurt am Main

63263

Neu-Isenburg

80336

München

80539

München

81241

München

82131

Gauting

86899

Landsberg am Lech

Sponsors

Lead Sponsor

Bayer

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

Bayer

INDUSTRY